Epigenetic Control of the Immune Escape Mechanisms in Malignant Carcinomas

REFERENCES

• Alimonti, J., Q. J. Zhang, R. Gabathuler, G. Reid, S. S. Chen, and W. A. Jefferies. 2000. TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat. Biotechnol. 18:515–520.
   PubMed Web of Science ®Google Scholar
• Berger, S. L. 2002. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12:142–148.
   PubMed Web of Science ®Google Scholar
• Davie, J. R., and V. A. Spencer. 1999. Control of histone modifications. J. Cell Biochem. 75(Suppl. 32):141–148.
   Google Scholar
• Eberharter, A., and P. B. Becker. 2002. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 3:224–229.
   PubMed Web of Science ®Google Scholar
• Eberharter, A., R. Ferreira, and P. Becker. 2005. Dynamic chromatin: concerted nucleosome remodelling and acetylation. Biol. Chem. 386:745–751.
   PubMedGoogle Scholar
• Franks, L. M., A. W. Carbonell, V. J. Hemmings, and P. N. Riddle. 1976. Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor. Cancer Res. 36:1049–1055.
   PubMedGoogle Scholar
• Gabathuler, R., G. Reid, G. Kolaitis, J. Driscoll, and W. A. Jefferies. 1994. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med. 180:1415–1425.
   PubMed Web of Science ®Google Scholar
• Giordano, A., and M. L. Avantaggiati. 1999. p300 and CBP: partners for life and death. J. Cell Physiol. 181:218–230.
   PubMed Web of Science ®Google Scholar
• Giraud, S., F. Bienvenu, S. Avril, H. Gascan, D. M. Heery, and O. Coqueret. 2002. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J. Biol. Chem. 277:8004–8011.
   PubMed Web of Science ®Google Scholar
• Gregory, P. D., K. Wagner, and W. Horz. 2001. Histone acetylation and chromatin remodeling. Exp. Cell Res. 265:195–202.
   PubMed Web of Science ®Google Scholar
• Johnsen, A. K., D. J. Templeton, M. Sy, and C. V. Harding. 1999. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J. Immunol. 163:4224–4231.
   PubMed Web of Science ®Google Scholar
• Kageshita, T., S. Hirai, T. Ono, D. J. Hicklin, and S. Ferrone. 1999. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am. J. Pathol. 154:745–754.
   PubMed Web of Science ®Google Scholar
• Kalkhoven, E. 2004. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68:1145–1155.
   PubMed Web of Science ®Google Scholar
• Keen, J. C., E. Garrett-Mayer, C. Pettit, K. M. Mack, J. Manning, J. G. Herman, and N. E. Davidson. 2004. Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells. Cancer Biol. Ther. 3:1304–1312.
   PubMed Web of Science ®Google Scholar
• Klenova, E. M., H. C. Morse III, R. Ohlsson, and V. V. Lobanenkov. 2002. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin. Cancer Biol. 12:399–414.
   PubMedGoogle Scholar
• Lankat-Buttgereit, B., and R. Tampe. 2002. The transporter associated with antigen processing: function and implications in human diseases. Physiol. Rev. 82:187–204.
   PubMedGoogle Scholar
• Lee, H. M., T. L. Timme, and T. C. Thompson. 2000. Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cells. Cancer Res. 60:1927–1933.
   PubMedGoogle Scholar
• Legube, G., and D. Trouche. 2003. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 4:944–947.
   PubMed Web of Science ®Google Scholar
• Lin, K. Y., F. G. Guarnieri, K. F. Staveley-O'Carroll, H. I. Levitsky, J. T. August, D. M. Pardoll, and T. C. Wu. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56:21–26.
   PubMed Web of Science ®Google Scholar
• Lund, A. H., and M. van Lohuizen. 2004. Epigenetics and cancer. Genes Dev. 18:2315–2335.
   PubMed Web of Science ®Google Scholar
• Mahadevan, L. C., A. L. Clayton, C. A. Hazzalin, and S. Thomson. 2004. Phosphorylation and acetylation of histone H3 at inducible genes: two controversies revisited. Novartis Found. Symp. 259:102–111; discussion, 111-114, 163-169.
   PubMedGoogle Scholar
• Reference deleted.
   Google Scholar
• Matsui, M., S. Machida, T. Itani-Yohda, and T. Akatsuka. 2002. Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-gamma. J. Gastroenterol. Hepatol. 17:897–907.
   PubMedGoogle Scholar
• Mikyskova, R., J. Bubenik, V. Vonka, M. Smahel, M. Indrova, J. Bieblova, J. Simova, and T. Jandlova. 2005. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy. Int. J. Oncol. 26:521–527.
   PubMedGoogle Scholar
• Poste, G., J. Doll, I. R. Hart, and I. J. Fidler. 1980. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 40:1636–1644.
   PubMed Web of Science ®Google Scholar
• Ritz, U., and B. Seliger. 2001. The transporter associated with antigen processing (TAP): structural integrity, expression, function, and its clinical relevance. Mol. Med. 7:149–158.
   PubMed Web of Science ®Google Scholar
• Seliger, B., M. J. Maeurer, and S. Ferrone. 2000. Antigen-processing machinery breakdown and tumor growth. Immunol. Today 21:455–464.
   PubMedGoogle Scholar
• Seliger, B., M. J. Maeurer, and S. Ferrone. 1997. TAP off—tumors on. Immunol. Today 18:292–299.
   PubMedGoogle Scholar
• Seliger, B., U. Wollscheid, F. Momburg, T. Blankenstein, and C. Huber. 2000. Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin. Tissue Antigens 56:327–336.
   PubMed Web of Science ®Google Scholar
• Setiadi, A. F., M. D. David, S. S. Chen, J. Hiscott, and W. A. Jefferies. 2005. Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas. Cancer Res. 65:7485–7492.
   PubMedGoogle Scholar
• Smahel, M., P. Sima, V. Ludvikova, I. Marinov, D. Pokorna, and V. Vonka. 2003. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules. Vaccine 21:1125–1136.
   PubMedGoogle Scholar
• Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599–606.
   PubMed Web of Science ®Google Scholar